Addus Homecare Corp
NASDAQ:ADUS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
82.05
133.58
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Addus Homecare Corp
Wall Street
Price Targets
ADUS Price Targets Summary
Addus Homecare Corp
According to Wall Street analysts, the average 1-year price target for
ADUS
is 140.05 USD
with a low forecast of 83.83 USD and a high forecast of 162.75 USD.
ADUS Last Price Targets
Addus Homecare Corp
The latest public price target was made on Nov 6, 2024 by
Scott Fidel
from
Stephens
,
who expects
ADUS
stock to
rise by 15%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Scott Fidel
Stephens
|
145
USD
Upside 15% |
1 week ago
Nov 6, 2024
|
Addus HomeCare (ADUS) PT Raised to $145 at Stephens
StreetInsider
|
Matthew Gillmor
KeyBanc
|
150
USD
Upside 19% |
1 month ago
Oct 10, 2024
|
Addus HomeCare initiated with an Overweight at KeyBanc
TheFly
|
Michael Wiederhorn
Oppenheimer
|
145
USD
Upside 15% |
1 month ago
Sep 23, 2024
|
Addus HomeCare (ADUS) PT Raised to $145 at Oppenheimer
StreetInsider
|
Frank Morgan
RBC Capital
|
141
USD
Upside 12% |
3 months ago
Aug 8, 2024
|
Addus HomeCare (ADUS) PT Raised to $141 at RBC Capital
StreetInsider
|
|
Michael Wiederhorn
Oppenheimer
|
140
USD
Upside 11% |
3 months ago
Aug 7, 2024
|
Addus HomeCare (ADUS) PT Raised to $140 at Oppenheimer
StreetInsider
|
|
Michael Wiederhorn
Oppenheimer
|
130
USD
Upside 3% |
5 months ago
Jun 7, 2024
|
Addus HomeCare (ADUS) PT Raised to $130 at Oppenheimer
StreetInsider
|
|
Scott Fidel
Stephens
|
128
USD
Upside 1% |
5 months ago
May 31, 2024
|
Addus HomeCare (ADUS) PT Raised to $128 at Stephens
StreetInsider
|
|
Frank Morgan
RBC Capital
|
129
USD
Upside 2% |
5 months ago
May 28, 2024
|
Addus HomeCare (ADUS) PT Raised to $129 at RBC Capital
StreetInsider
|
Andrew Mok
Barclays
|
83
USD
Downside 34% |
6 months ago
Apr 23, 2024
|
Barclays downgrades Addus to Underweight on 'materially negative' regulation
TheFly
|
|
Scott Fidel
Stephens
|
115
USD
Downside 9% |
7 months ago
Apr 1, 2024
|
Addus HomeCare price target raised to $115 from $110 at Stephens
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ADUS's stock price target?
Price Target
140.05
USD
According to Wall Street analysts, the average 1-year price target for
ADUS
is 140.05 USD
with a low forecast of 83.83 USD and a high forecast of 162.75 USD.
What is Addus Homecare Corp's Revenue forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's revenue is
15%.
The projected
CAGR
for the next 3 years is
13%.
What is Addus Homecare Corp's Operating Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's operating income is
24%.
The projected
CAGR
for the next 3 years is
20%.
What is Addus Homecare Corp's Net Income forecast?
Projected CAGR
25%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's net income is
23%.
The projected
CAGR
for the next 3 years is
25%.
You don't have any saved screeners yet
